RNF5 is required for AML growth. Protein could be inhibited or used as a biomarker to improve patient outcomes. — ScienceDaily
A new study led by scientists at Sanford Burnham Prebys has shown that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). Unlike its expected role, marking…
